Hyperfractionated radiation therapy: Clinical Trials

4 trials of Hyperfractionated radiation therapy, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 3, Terminated 1
Phase 21Completed 1

Follow Hyperfractionated radiation therapy: new trials by email Literature Review of Hyperfractionated radiation therapy trials Research Report on Hyperfractionated radiation therapy

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
Hyperfractionated radiation therapy, Stereotactic radiosurgery, Alisertib - Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma
Phase 1CompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University172015-01-302025-04-30
Chemoradiation and Radiosurgery Boost in Treating Patients With Locally Advance Pancreatic Cancer That May or May Not be Removed by Surgery
gemcitabine hydrochloride, hyperfractionated radiation therapy, intensity-modulated radiation therapy - Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas
Phase 1TerminatedFox Chase Cancer Center62013-05-012019-07-29
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin Followed By Chemoradiation in Treating Patients With Recurrent Head and Neck Cancer
carboplatin, paclitaxel albumin-stabilized nanoparticle formulation, fluorouracil - Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx
Phase 1CompletedUniversity of Chicago482013-03-262024-07-31
Cisplatin, Fluorouracil, Iressa, and Radiation Therapy Patients With Locally Advanced Head and Neck Cancer
cisplatin, fluorouracil, Iressa - Head and Neck Cancer
Phase 1 / Phase 2CompletedDavid Adelstein602006-04-012012-11-05

Conditions studied

Squamous Cell Carcinoma of Head and Neck (2)  ·  Astrocytoma (1)  ·  Brain Neoplasms (1)  ·  Ependymoma (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  Gliosarcoma (1)  ·  Head and Neck Neoplasms (1)  ·  Oligodendroglioma (1)  ·  Pancreatic Neoplasms (1)  ·  Salivary Gland Neoplasms (1)  ·  Tongue Neoplasms (1)

Sponsors

David Adelstein (1)  ·  Fox Chase Cancer Center (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)  ·  University of Chicago (1)

Countries

United States (4)

Top investigators

David J. Adelstein, MD (1)  ·  Jonas de Souza (1)  ·  Joshua Meyer (1)  ·  Wenyin Shi, MD, PhD (1)

Results publications

PMID 30825962, PMID 35945244

NIH funding

P30CA043703 (1)